Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.
Saved in:
| Title: | Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534. |
|---|---|
| Authors: | Xue X; Janssen Research & Development, LLC, La Jolla, CA, USA. xxue@its.jnj.com., De Leon-Tabaldo A; Janssen Research & Development, LLC, La Jolla, CA, USA., Luna-Roman R; Janssen Research & Development, LLC, La Jolla, CA, USA., Castro G; Janssen Research & Development, LLC, Spring House, PA, USA., Albers M; Department of Research, Phenex Pharmaceuticals AG, Heidelberg, Germany., Schoetens F; Janssen Research & Development, LLC, La Jolla, CA, USA., DePrimo S; Janssen Research & Development, LLC, La Jolla, CA, USA., Devineni D; Janssen Research & Development, LLC, Spring House, PA, USA., Wilde T; Janssen Research & Development, LLC, Spring House, PA, USA., Goldberg S; Janssen Research & Development, LLC, La Jolla, CA, USA., Kinzel O; Department of Research, Phenex Pharmaceuticals AG, Heidelberg, Germany., Hoffmann T; Department of Research, Phenex Pharmaceuticals AG, Heidelberg, Germany., Fourie AM; Janssen Research & Development, LLC, La Jolla, CA, USA., Thurmond RL; Janssen Research & Development, LLC, La Jolla, CA, USA. RTHURMON@its.jnj.com. |
| Source: | Scientific reports [Sci Rep] 2022 Apr 06; Vol. 12 (1), pp. 5740. Date of Electronic Publication: 2022 Apr 06. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
